Research & Development

Gestational Diabetes Does Not Predispose Infants to Obesity: Study Shows
Research & Development Gestational Diabetes Does Not Predispose Infants to Obesity: Study Shows

A groundbreaking study led by researchers from The University of Texas at Austin and Harvard Medical School has challenged the prevailing assumption that infants exposed to gestational diabetes mellitus (GDM) are at an automatically higher risk of developing childhood obesity. Published in the

Can New Antibodies Combat Age-Related Muscle Atrophy Effectively?
Research & Development Can New Antibodies Combat Age-Related Muscle Atrophy Effectively?

In the quest to improve the quality of life for the aging population, a research team from Kyushu University has made a groundbreaking discovery that may pave the way for combating age-related muscle atrophy. As people age, the decline in muscle mass and function becomes a significant concern,

SARS-CoV-2 Hijacks Cholesterol Pathways: New Therapeutic Targets Identified
Research & Development SARS-CoV-2 Hijacks Cholesterol Pathways: New Therapeutic Targets Identified

The intricate dance between viruses and the host cells they infect has always been a subject of intense scientific inquiry. Recent research into SARS-CoV-2, the virus at the heart of the COVID-19 pandemic, has revealed a sophisticated mechanism through which this pathogen manipulates host

Can Probiotics, Prebiotics, and Synbiotics Manage PCOS Effectively?
Research & Development Can Probiotics, Prebiotics, and Synbiotics Manage PCOS Effectively?

Polycystic Ovary Syndrome (PCOS) is a common hormonal disorder affecting women of reproductive age. Characterized by symptoms such as irregular menstrual cycles, excessive androgen levels, and ovarian cysts, PCOS is also associated with significant metabolic complications like insulin resistance,

Who Is Eligible for Semaglutide for Diabetes and Cardiovascular Health?
Research & Development Who Is Eligible for Semaglutide for Diabetes and Cardiovascular Health?

The eligibility criteria for semaglutide, a medication that has seen rapidly expanded use beyond its initial approval for type 2 diabetes, reflect broader implications for healthcare policies and pharmaceutical budgets in the United States. Initially, semaglutide was approved by the US Food and

Tampa General Gets C Grade in Hospital Safety; Other FL Hospitals Excel
Research & Development Tampa General Gets C Grade in Hospital Safety; Other FL Hospitals Excel

The recent hospital safety ratings in Florida have sparked significant discussion, especially with Tampa General Hospital receiving a C grade from Leapfrog, an independent nonprofit that rates hospital safety. This rating marks the fifth time in the last six Leapfrog assessments that the hospital

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later